Somatostatin antagonist induces catalepsy in the aged rat
Authors:
- 29 December 2012
- journal article
- research article
- Published by Springer Nature in Psychopharmacology
- Vol. 227 (2) , 273-276
Abstract
Extrapyramidal motor signs are the major features of Parkinson’s disease (PD). It is unclear whether there is a link between these signs and such PD-associated factors as brain somatostatin deficiency and aging. This study aimed to examine whether an inhibition of the brain somatostatin system can initiate catalepsy, a model of extrapyramidal disorders, in young and aged rats. The animals of 100–110 and 540–560 days of age were used. Catalepsy was measured using the bar test. The inhibition of the brain somatostatin activity was simulated by intracerebroventricular administration of a somatostatin antagonist, cyclosomatostatin. Cyclosomatostatin dose-dependently induced catalepsy in aged, but not in young rats. The cataleptic response was reversed by a somatostatin analog, octreotide. The combination of aging and brain somatostatin deficiency can lead to catalepsy in rats. Since both factors are frequently observed in PD patients, the present results might be of relevance for pathogenesis of extrapyramidal signs in this disease.Keywords
This publication has 28 references indexed in Scilit:
- Constitutive Somatostatin Receptor Activity Determines Tonic Pituitary Cell ResponseMolecular Endocrinology, 2009
- Central resistance to the inhibitory effects of leptin on stimulated insulin secretion with agingNeurobiology of Aging, 2006
- Dopamine D2 Receptor Occupancy Is a Common Mechanism Underlying Animal Models of Antipsychotics and Their Clinical EffectsNeuropsychopharmacology, 2001
- Somatostatin-like immunoreactivity, its molecular forms and monoaminergic metabolites in aged and demented patients with Parkinson's disease ? effect of L-DopaJournal of Neural Transmission, 1996
- Increased Pituitary Response to Somatostatin in Aging Male Rats: Relationship to Somatostatin Receptor Number and AffinityNeuroendocrinology, 1989
- Intra-cerebral cysteamine infusions attenuate the motor response to dopaminergic agonistsBehavioural Brain Research, 1988
- The effects of cysteamine on dopamine-mediated behaviors: Evidence for dopamine-somatostatin interactions in the striatumPharmacology Biochemistry and Behavior, 1986
- Studies of the mechanism of the cardiovascular action of central injections of histamineNeuropharmacology, 1983
- Correlation between multitest and single test catalepsy assessmentNeuropharmacology, 1978
- Catalepsy induced by morphine or haloperidol: effects of apomorphine and anticholinergic drugsCanadian Journal of Physiology and Pharmacology, 1976